BMS-284756与四种氟喹诺酮类药物对肺炎链球菌的体外活性比较。 - Suppr

Suppr

超能文献

Comparison of the in vitro activities of BMS-284756 and four fluoroquinolones against Streptococcus pneumoniae.

作者信息

Boswell F J, Andrews J M, Wise R

出版信息

J Antimicrob Chemother. 2001 Sep;48(3):446-7. doi: 10.1093/jac/48.3.446.

DOI:10.1093/jac/48.3.446

PMID:11533016

Abstract

摘要

相似文献

Comparison of the in vitro activities of BMS-284756 and four fluoroquinolones against Streptococcus pneumoniae.

J Antimicrob Chemother. 2001 Sep;48(3):446-7. doi: 10.1093/jac/48.3.446.

Single- and multistep selection study of the antipneumococcal activity of BMS-284756 compared to ciprofloxacin, levofloxacin, trovafloxacin and moxifloxacin.

Clin Microbiol Infect. 2002 Jun;8(6):373-80. doi: 10.1046/j.1469-0691.2002.00405.x.

Comparative bactericidal activities of ciprofloxacin, clinafloxacin, grepafloxacin, levofloxacin, moxifloxacin, and trovafloxacin against Streptococcus pneumoniae in a dynamic in vitro model.

Antimicrob Agents Chemother. 2001 Mar;45(3):673-8. doi: 10.1128/AAC.45.3.673-678.2001.

Antimicrobial activity of moxifloxacin, gatifloxacin and six fluoroquinolones against Streptococcus pneumoniae.

J Antimicrob Chemother. 2001 Jun;47(6):875-7. doi: 10.1093/jac/47.6.875.

Comparative activity of trovafloxacin and Bay 12-8039 against 452 clinical isolates of Streptococcus pneumoniae.

J Antimicrob Chemother. 1998 Oct;42(4):523-5. doi: 10.1093/jac/42.4.523.

Activity of moxifloxacin and other quinolones against pneumococci resistant to first-line agents, or with high-level ciprofloxacin resistance.

Int J Antimicrob Agents. 2001 May;17(5):377-81. doi: 10.1016/s0924-8579(01)00316-8.

In vitro development of resistance to three quinolones in Streptococcus pneumoniae.

Chemotherapy. 2001 Jan-Feb;47(1):39-42. doi: 10.1159/000048499.

Antipneumococcal activity of BMS 284756 compared to those of six other agents.

Antimicrob Agents Chemother. 2002 Jan;46(1):251-4. doi: 10.1128/AAC.46.1.251-254.2002.

Moxifloxacin: a comparison with other antimicrobial agents of in-vitro activity against Streptococcus pneumoniae.

J Antimicrob Chemother. 1998 Dec;42(6):803-6. doi: 10.1093/jac/42.6.803.

Activity of moxifloxacin against clinical isolates of Streptococcus pneumoniae from England and Wales.

J Antimicrob Chemother. 2001 Apr;47(4):411-5. doi: 10.1093/jac/47.4.411.

引用本文的文献

Activities of garenoxacin against quinolone-resistant Streptococcus pneumoniae strains in vitro and in a mouse pneumonia model.

Antimicrob Agents Chemother. 2004 Mar;48(3):765-73. doi: 10.1128/AAC.48.3.765-773.2004.

In vitro activities of garenoxacin (BMS-284756) against Streptococcus pneumoniae, viridans group streptococci, and Enterococcus faecalis compared to those of six other quinolones.

Antimicrob Agents Chemother. 2003 Nov;47(11):3542-7. doi: 10.1128/AAC.47.11.3542-3547.2003.

In vitro activities of garenoxacin (BMS-284756) against Haemophilus influenzae isolates with different fluoroquinolone susceptibilities.

Antimicrob Agents Chemother. 2003 Nov;47(11):3539-41. doi: 10.1128/AAC.47.11.3539-3541.2003.

Fluoroquinolone-resistant Streptococcus pneumoniae in Spain: activities of garenoxacin against clinical isolates including strains with altered topoisomerases.

Antimicrob Agents Chemother. 2003 Aug;47(8):2692-5. doi: 10.1128/AAC.47.8.2692-2695.2003.

In vitro antibacterial activity and pharmacodynamics of new quinolones.

Eur J Clin Microbiol Infect Dis. 2003 Apr;22(4):203-21. doi: 10.1007/s10096-003-0907-5. Epub 2003 Apr 1.

Dual targeting of DNA gyrase and topoisomerase IV: target interactions of garenoxacin (BMS-284756, T-3811ME), a new desfluoroquinolone.

Antimicrob Agents Chemother. 2002 Nov;46(11):3370-80. doi: 10.1128/AAC.46.11.3370-3380.2002.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验